Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TMEM68 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DDX20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUDT15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SF3B3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANAPC13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VEZT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF3M - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTPAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRNP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF721 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TAF1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OSBPL9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERPINC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SBDSP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANP32E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LDB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TIGD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MASP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLMN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on